ArticleMedical archives (Sarajevo, Bosnia and Herzegovina)2025
Comparative Embryological Outcomes of Vitrified and Fresh Oocytes in Patients with Diminished Ovarian Reserve.
Article in Medical archives (Sarajevo, Bosnia and Herzegovina), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The number of oocytes retrieved is a key determinant of in-vitro fertilization (IVF) success, positively associated with fertilization rate, blastocyst formation, and cumulative live birth outcomes. Optimal results are observed in cycles retrieving 16-20 oocytes, with no decline in cumulative live birth rate at higher yields. Objective: This study aimed to compare embryological outcomes between vitrified and fresh oocytes in the same patients with diminished ovarian reserve. Methods: This retrospective study included 114 women with diminished ovarian reserve (DOR) who underwent oocyte accumulation using both vitrified and fresh oocytes between June 2021 and January 2025. A total of 400 vitrified and 291 fresh oocytes were analyzed. The survival rate, fertilization rate, cleavage rate, and day-2 embryo quality were compared. Subgroup analysis was performed according to POSEIDON groups 3 (<35 years) and 4 (≥35 years). Pregnancy outcomes were preliminarily evaluated in 52 patients who underwent frozen embryo transfer using embryos derived from both oocyte types. Results: The mean survival rate was 93.1% ± 14.6%. No significant differences were observed between vitrified and fresh oocytes in fertilization rate (79.7% vs. 86.0%, p = 0.41), cleavage rate (90.8% vs. 93.9%, p = 0.31), or day-2 embryo quality (p > 0.05). Embryological outcomes were comparable in both POSEIDON 3 and 4 groups. In group 4, the proportion of grade 3 embryos was higher in the vitrified oocyte group than in the fresh group (16.0% vs. 9.5%), but this difference was not statistically significant. The overall pregnancy and clinical pregnancy rates were 51.9% and 36.5%, respectively. Conclusion: Oocyte vitrification is a feasible and effective strategy for oocyte accumulation in women with DOR, yielding comparable embryological outcomes to fresh oocytes. This approach may offer a valuable option for improving reproductive outcomes in low-prognosis patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.